Publications

  1. Kinsman KA, White ML, Mynderse LA, Kawashima A, Rampton K, Gorny KR, Atwell TD, Felmlee JP, Callstrom MR, Woodrum DA. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up. Cardiovasc Intervent Radiol. 2017 Oct 17 [Epub ahead of print]
    View PubMed
  2. Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ. Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11C-Choline Positron Emission Tomography and Multiparametric Pelvic MRI. J Urol. 2017 Sep 12 Epub 2017 Sept 12
    View PubMed
  3. Olson MC, Atwell TD, Mynderse LA, King BF, Welch T, Goenka AH. CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experience. Eur Radiol. 2017 Aug; 27 (8):3326-3332 Epub 2016 Dec 14
    View PubMed
  4. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Prostate cancer: state of the art imaging and focal treatment. Clin Radiol. 2017 Aug; 72: (8)665-679.
    View PubMed
  5. Stish BJ, Davis BJ, Mynderse LA, Deufel CL, Choo R. Brachytherapy in the Management of Prostate Cancer. Surg Oncol Clin N Am. 2017 Jul; 26: (3)491-513.
    View PubMed
  6. Riederer SJ, Borisch EA, Froemming AT, Grimm RC, Kawashima A, Mynderse LA, Trzasko JD. Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array. Magn Reson Imaging. 2017 Jun; 39:15-23.
    View PubMed
  7. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission TomographyComputed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71: (3)340-348.
    View PubMed
  8. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 01; 97: (3)526-535.
    View PubMed
  9. Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil. Pract Radiat Oncol. 2017 Jan - Feb; 7: (1)42-49.
    View PubMed
  10. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with 11C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging. J Urol. 2017 Jan; 197: (1)129-134.
    View PubMed
  11. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. Contemporary mapping of post-prostatectomy prostate cancer relapse with c-11-choline positron emission tomography and multiparametric magnetic resonance imaging Journal Of Urology. 2017 Jan; 197: (1)129-34.
  12. Bayat M, Kumar V, Denis M, Webb J, Gregory A, Mehrmohammadi M, Cheong M, Husmann D, Mynderse L, Alizad A, Fatemi M. Correlation of ultrasound bladder vibrometry assessment of bladder compliance with urodynamic study results. PLoS One. 2017; 12 (6):e0179598 Epub 2017 June 16
    View PubMed
  13. Zattoni F, Nehra A, Murphy CR, Rangel L, Mynderse L, Lowe V, Kwon E, Karnes RJ. Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy. Eur Urol Focus. 2016 Dec; 2: (5)522-531.
    View PubMed
  14. Birckhead BJ, Fossum CC, Deufel CL, Furutani KM, Merrell KW, Schueler BA, Mynderse LA, Choo R, Davis BJ. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray. Brachytherapy. 2016 Nov - Dec; 15: (6)714-721.
    View PubMed
  15. Birekhead BJ, Fossum CC, Deufel CL, Furutani KM, Merrell KW, Schueler BA, Mynderse LA, Choo R, Davis BJ. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by day 0 fluoroscopy and 4-month postimplant pelvic x-ray Brachytherapy. 2016 Nov-dec; 15: (6)714-21.
  16. McLaren RH, Mynderse LA, Davis BJ, Kwon ED, Lowe VJ, Nathan MA, Karnes R, Parker WP. The Utility of C11 Choline PET/CT in Post-prostatectomy Patients with Biochemical Recurrence: a Comparison to mpMRI. World Jnl of Urol.2016;().
  17. Evans JD, Davis BJ, Stish BJ, Park SS, Olivier K, Choo CR, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ. Recurrence Patterns of Oligometastatic Disease Detected Using C-11 Choline Positron Emission Tomography/Computed Tomography in Patients With a Rising Prostate-Specific Antigen Level Following Postprostatectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S103.
    View PubMed
  18. Parker WP, Davis BJ, Park SS, Olivier K, Choo CR, Nathan MA, Lowe VJ, Welch TJ, Zaid HB, Sobol II, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes JR, Kwon ED. Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S112.
    View PubMed
  19. Jethwa KR, Furutani KM, Mynderse LA, Wilson TM, Choo R, King BF, Bergstralh E, Davis BJ. Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression. J Contemp Brachytherapy. 2016 Oct; 8 (5):371-378 Epub 2016 Nov 04
    View PubMed
  20. Woodrum DA, Gorny KR, Greenwood B, Mynderse LA. MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer. Semin Intervent Radiol. 2016 Sep; 33 (3):196-205
    View PubMed
  21. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study. J Sex Med. 2016 Jun; 13: (6)924-33.
    View PubMed
  22. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Response and Rebuttal to Editorial Commentary on "Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study". J Sex Med. 2016 Jun; 13: (6)936-7.
    View PubMed
  23. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25: (5)605-9.
    View PubMed
  24. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Targeted prostate biopsy and MR-guided therapy for prostate cancer. Abdom Radiol (NY). 2016 May; 41 (5):877-88
    View PubMed
  25. McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Rousseau M, Beahrs JR, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Larson TR, Dixon CM, Roehrborn CG. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2016 May; 195: (5)1529-38.
    View PubMed
  26. Nenadic I, Mynderse L, Husmann D, Mehrmohammadi M, Bayat M, Singh A, Denis M, Urban M, Alizad A, Fatemi M. Noninvasive Evaluation of Bladder Wall Mechanical Properties as a Function of Filling Volume: Potential Application in Bladder Compliance Assessment. PLoS One. 2016; 11: (6)e0157818.
    View PubMed
  27. Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Larson TR, Mynderse LA. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol. 2016; 8:207-216.
    View PubMed
  28. Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Mynderse L, Larson T. Efficacy and Safety of Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urology. 2015 Nov; 86: (5)1042-7.
    View PubMed
  29. Woodrum DA, Kawashima A, Gorny KR, Mynderse LA. Magnetic Resonance-Guided Thermal Therapy for Localized and Recurrent Prostate Cancer. Magn Reson Imaging Clin N Am. 2015 Nov; 23: (4)607-19.
    View PubMed
  30. Mynderse LA, Hanson D, Robb RA, Pacik D, Vit V, Varga G, Wagrell L, Tornblom M, Cedano ER, Woodrum DA, Dixon CM, Larson TR. Rezum System Water Vapor Treatment for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Validation of Convective Thermal Energy Transfer and Characterization With Magnetic Resonance Imaging and 3-Dimensional Renderings. Urology. 2015 Jul; 86(1):122-7. Epub 2015 May 16.
    View PubMed
  31. Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int. 2015 Feb; 115: (2)295-9.
    View PubMed
  32. Karnes RJ, Murphy CR, Bergstralh EJ, DiMonte G, Cheville JC, Lowe VJ, Mynderse LA, Kwon ED. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography. J Urol. 2015 Jan; 193(1):111-6. Epub 2014 Aug 20.
    View PubMed
  33. Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezum((R)) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015; 7:13-8.
    View PubMed
  34. Holmes DR 3rd, Davis BJ, Goulet CC, Wilson TM, Mynderse LA, Furutani KM, Camp JJ, Robb RA. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance. Brachytherapy. 2014 Sep-Oct; 13: (5)465-70.
    View PubMed
  35. Favazza CP, Gorny KR, King DM, Rossman PJ, Felmlee JP, Woodrum DA, Mynderse LA. An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. Cryobiology. 2014 Aug; 69(1):128-33. Epub 2014 Jun 27.
    View PubMed
  36. Ahmed KA, Davis BJ, Mynderse LA, Slezak JM, Bergstralh EJ, Wilson TM, Choo CR. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'. Radiat Oncol. 2014 Jul 29; 9:171.
    View PubMed
  37. Davis BJ, Leenstra JL, Wilson TM, Mynderse LA, Solhjem MC, Herman MG, Hillman DW, Allen-Ziegler KL, Cheville JC, King BF, Holmes III DR. Prostate Volume in Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Imaging and Treatment Devices for the Prostate. OMICS J Radiol S1. June 6, 2014(S1).
  38. Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, Rangel LJ, King BF, Mynderse LA. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging. Can J Urol. 2014 Jun; 21(3):7283-9.
    View PubMed
  39. Yelfimov D, Mynderse LA, Tollefson MK. In Vivo magnetic resonance elastography to image prostate anatomy in patients with prostate cancer: a feasibility study J Urol.2014;
  40. Tollefson MK, Karnes RJ, Kwon ED, Lohse CM, Rangel LJ, Mynderse LA, Cheville JC, Sebo TJ. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. Mayo Clin Proc. 2014 Mar; 89(3):308-18. Epub 2014 Jan 31.
    View PubMed
  41. Mitchell CR, Mynderse LA, Lightner DJ, Husmann DA, Krambeck AE. Efficacy of holmium laser enucleation of the prostate in patients with non-neurogenic impaired bladder contractility: results of a prospective trial. Urology. 2014 Feb; 83(2):428-32. Epub 2013 Nov 12.
    View PubMed
  42. Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int. 2014; 115(2):295-9.
  43. Woodrum DA, Kawashima A, Karnes RJ, Davis BJ, Frank I, Engen DE, Gorny KR, Felmlee JP, Callstrom MR, Mynderse LA. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. Urology. 2013 Oct; 82(4):870-5. Epub 2013 Aug 01.
    View PubMed
  44. Childs MA, Mynderse LA, Rangel LJ, Wilson TM, Lingeman JE, Krambeck AE. Pathogenesis of bladder calculi in the presence of urinary stasis. J Urol. 2013 Apr; 189: (4)1347-51.
    View PubMed
  45. Alizad A, Mehrmohammadi M, Mitri FG, Davis BJ, Sebo TJ, Mynderse LA, Kinnick RR, Greenleaf JF, Fatemi M. Application of vibro-acoustography in prostate tissue imaging. Med Phys. 2013 Feb; 40: (2)022902.
    View PubMed
  46. Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012 Jul; 188(1):58-62. Epub 2012 May 12.
    View PubMed
  47. Crawford ED, Hirst K, Kusek JW, Donnell RF, Kaplan SA, McVary KT, Mynderse LA, Roehrborn CG, Smith CP, Bruskewitz R. Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trial. J Urol. 2011 Sep; 186(3):965-70. Epub 2011 Jul 24.
    View PubMed
  48. Woodrum DA, Mynderse LA, Gorny KR, Amrami KK, McNichols RJ, Callstrom MR. 3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol. 2011 Jul; 22(7):929-34.
    View PubMed
  49. Mynderse LA, Roehrborn CG, Partin AW, Preminger GM, Cote EP. Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol. 2011 May; 185(5):1804-10. Epub 2011 Mar 21.
    View PubMed
  50. Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010 Nov; 184(5):1907-13. Epub 2010 Sep 17.
    View PubMed
  51. Woodrum DA, Gorny KR, Mynderse LA, Amrami KK, Felmlee JP, Bjarnason H, Garcia-Medina OI, McNichols RJ, Atwell TD, Callstrom MR. Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. Urology. 2010 Jun; 75(6):1514.e1-6. Epub 2010 Apr 09.
    View PubMed
  52. McPhail EF, Mynderse LA, Callstrom MR, Gorny KR, McNichols RJ, Atwell TD, Gettman MT, Amrami KK, Kawashima A, Woodrum DA. 1.5T MRI-guided trans-perineal laser ablation of locally recurrent prostate adenocarcinoma. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2010; 7548:754816.
  53. Huidobro C, Larson B, Mynderse S, Myers JJ, Busel D, Acevedo C, Larson TR, Mynderse LA. Characterizing Prostiva RF treatments of the prostate for BPH with gadolinium-enhanced MRI. ScientificWorldJournal. 2009; 9:10-6. Epub 2009 Jan 18.
    View PubMed
  54. Pisansky TM, Gold DG, Furutani KM, Macdonald OK, McLaren RH, Mynderse LA, Wilson TM, Hebl JR, Choo R. High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer. Mayo Clin Proc. 2008 Dec; 83(12):1364-72.
    View PubMed
  55. Mitri FG, Davis BJ, Alizad A, Greenleaf JF, Wilson TM, Mynderse LA, Fatemi M. Prostate cryotherapy monitoring using vibroacoustography: preliminary results of an ex vivo study and technical feasibility. IEEE Trans Biomed Eng. 2008 Nov; 55: (11)2584-92.
    View PubMed
  56. Dilger JA, Walsh MT, Warner ME, Mynderse LA, Sprung J. Urethral injury during potassium-titanyl-phosphate laser prostatectomy complicated by transurethral resection syndrome. Anesth Analg. 2008 Oct; 107(4):1438-40.
    View PubMed
  57. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008 May; 53(5):976-81. Epub 2007 Nov 05.
    View PubMed
  58. Larson BT, Mynderse LA, Somers VK, Jaff MR, Evans WP, Larson TR. Blood pressure surges during office-based transurethral microwave therapy for the prostate. Mayo Clin Proc. 2008 Mar; 83(3):309-12.
    View PubMed
  59. Mynderse LA, Larson B, Huidobro C, Meyer JJ, Busel D, Hanson DP, Larson T. Characterizing TUNA ablative treatments of the prostate for benign hyperplasia with gadolinium-enhanced magnetic resonance imaging. J Endourol. 2007 Nov; 21: (11)1361-6.
    View PubMed
  60. Ashley RA, Inman BA, Routh JC, Krambeck AE, Siddiqui SA, Mynderse LA, Gettman MT, Blute ML. Preventing pain during office biopsy of the prostate: a single center, prospective, double-blind, 3-arm, parallel group, randomized clinical trial. Cancer. 2007 Oct 15; 110: (8)1708-14.
    View PubMed
  61. Schwartz DJ, Sengupta S, Hillman DW, Sargent DJ, Cheville JC, Wilson TM, Mynderse LA, Choo R, Davis BJ. Prediction of radial distance of extraprostatic extension from pretherapy factors. Int J Radiat Oncol Biol Phys. 2007 Oct 1; 69(2):411-8.
    View PubMed
  62. Siddiqui SA, Mynderse LA, Zincke H, Hoffmann NE, Lobo JR, Wilson TM, Kawashima A, Davis BJ, Blute ML. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience. Urology. 2007 Jul; 70(1):80-5.
    View PubMed
  63. Holmes DR, Davis BJ, Hangiandreou NJ, Kinnick RR, Wilson TM, Mynderse LA, Robb RA. Design and testing of a custom transurethral ultrasound device with rapid 3D reconstruction using a rotational scanner. Brachytherapy. 2007 Apr-Jun; 6(2):94.
  64. Sengupta S, Davis BJ, Mynderse LA, Sebo TJ, Cheville JC, Lohse CM, Hillman DW, Haddock MG, Wilson TM. Permanent prostate brachytherapy: pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy. Urology. 2006 Oct; 68(4):810-4.
    View PubMed
  65. Larson BT, Mynderse L, Ulchaker J, Pulling C, Larson TR. Transurethral microwave thermotherapy effectiveness in small prostates. Urology. 2006 Oct; 68(4):790-4.
    View PubMed
  66. Beckman T, Abu-Lebdeh H, Mynderse L. Erectile dysfunction and testosterone. Mayo Clin Proc.. 2006 Jun; 81: (6)853-4.
  67. Beckman TJ, Abu-Lebdeh HS, Mynderse LA. Evaluation and medical management of erectile dysfunction. Mayo Clin Proc. 2006 Mar; 81(3):385-90.
    View PubMed
  68. Beckman TJ, Mynderse LA. Evaluation and medical management of benign prostatic hyperplasia. Mayo Clin Proc. 2005 Oct; 80(10):1356-62.
    View PubMed
  69. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Herman MG, King BF, Geyer SM. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004 Nov 01; 60: (3)767-76.
    View PubMed
  70. Solhjem MC, Davis BJ, Pisansky TM, Wilson TM, Mynderse LA, Hillman DW, Herman MG, King BF. Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression. Cancer J. 2004 Nov-Dec; 10: (6)343-8.
    View PubMed
  71. Roehrborn C, Cote E, Larson T, Mynderse L, Partin A, Preminger G. Results of a multicenter trial of a new generation cooled TUMT for BPH. J Urol. 2004; 171(4):402-3.
    View PubMed
  72. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, Kim HL, Lugg J, Childs SJ, Shuman B, Jayson MA, Shore ND, Moore Y, Zisman A, Lee JY, Ugarte R, Mynderse LA, Wilson TM, Sweat SD, Zincke H, Belldegrun AS. Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience. J Urol. 2003 Oct; 170(4 Part 1):1126-30.
    View PubMed
  73. Mynderse LA, Larson TR. Transurethral hot water balloon thermotherapy for benign prostatic hyperplasia. Current Urology Reports. 2003 Aug; 4(4):287-91.
    View PubMed
  74. Mynderse LA, Monga M. Oral therapy for Peyronie's disease. Int J Impot Res. 2002 Oct; 14(5):340-4.
    View PubMed
  75. Martin SA, Mynderse LA, Lager DJ, Cheville JC. Juxtaglomerular cell tumor: a clinicopathologic study of four cases and review of the literature. Am J Clin Pathol. 2001 Dec; 116(6):854-63.
    View PubMed
  76. Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose M. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol. 1994 Mar; 151 (3):634-6
    View PubMed
  77. O'Sullivan DC, Mynderse L, Barrett DM. Subcutaneous port for longterm access and administration of topical chemotherapy to the upper urinary tract. J Urol. 1993 Sep; 150 (3):1034-7
    View PubMed
  78. O'Sullivan DC, Mynderse LA, Barrett D. Subcutaneous port for long-term access and administration of topical chemotherapy to the upper urinary tract. Journal of Urology (3). 1993 Sep; 150: 1034-7.
  79. Mynderse LA, Hassell JR, Kleinman HK, et al. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats. Laboratory Investigation. 1983 Mar; 48(3):292-302.
    View PubMed
  80. Mynderse LA, Martinez-Hernandez A, Kleinman HK, et al. Electron immunohistochemical localization of heparan sulfate in the glomerular basement membrane of nephrotic and normal rats. Federation Proceedings. 1982 Mar 5; 41(4).